KRAS Allelic Imbalance: Strengths and Weaknesses in Numbers
- PMID: 28372922
- DOI: 10.1016/j.molmed.2017.03.005
KRAS Allelic Imbalance: Strengths and Weaknesses in Numbers
Abstract
The identification of therapeutic vulnerabilities in mutant KRAS tumors has proven difficult to achieve. Burgess and colleagues recently reported in Cell that mutant/wild-type Kras allelic dosage determines clonal fitness and MEK inhibitor sensitivity in a leukemia model, demonstrating that KRAS allelic imbalance is likely an important and overlooked variable.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Comment on
-
KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer.Cell. 2017 Feb 23;168(5):817-829.e15. doi: 10.1016/j.cell.2017.01.020. Epub 2017 Feb 16. Cell. 2017. PMID: 28215705 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous